PureTech Health annual return on equity
2019
2020
2021
2022
2023
2024
2025
PureTech Health Return on Equity (ROE) Growth & History (PRTC)
PureTech Health's return on equity was −30.20% for fiscal 2025.
View full PureTech Health company overviewPureTech Health annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −30.20% | −36.52 pp |
| 2024 | 2024-12-31 | 6.32% | +19.57 pp |
| 2023 | 2023-12-31 | −13.24% | −6.72 pp |
| 2022 | 2022-12-31 | −6.53% | +3.40 pp |
| 2021 | 2021-12-31 | −9.93% | −10.61 pp |
| 2020 | 2020-12-31 | 0.68% | −86.89 pp |
| 2019 | 2019-12-31 | 87.57% | — |
PureTech Health return on equity trends
Over the last five fiscal years, PureTech Health's return on equity decreased from 0.68% to −30.20%, a change of −30.88 percentage points.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review PureTech Health source filings ↗